Watchlist Price Alert

Oruka Therapeutics Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

9.58

0.29 (3.12%)

At close: May 07, 2025, 3:17 PM

Oruka Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024
Period Ending	Dec 31, 2024	Sep 30, 2024
Net Income	-54.4M	-28.62M
Depreciation & Amortization	16K	n/a
Stock-Based Compensation	n/a	n/a
Other Working Capital	8.07M	5.93M
Other Non-Cash Items	-10.61M	-13.58M
Deferred Income Tax	n/a	n/a
Change in Working Capital	11.32M	7.34M
Operating Cash Flow	-53.67M	-34.86M
Capital Expenditures	-189K	-171K
Cash Acquisitions	n/a	n/a
Purchase of Investments	n/a	n/a
Sales Maturities Of Investments	n/a	n/a
Other Investing Acitivies	-329.94M	n/a
Investing Cash Flow	-330.13M	-171K
Debt Repayment	n/a	n/a
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	n/a	29.92M
Financial Cash Flow	449.52M	450.05M
Net Cash Flow	n/a	n/a
Free Cash Flow	-53.86M	-35.03M